NCT04553393 2020-12-04
Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden
Chinese PLA General Hospital
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT00439179 2020-02-17
BrUOG-PA205
Brown University
Phase 1 Completed
NCT02302339 2019-09-06
A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma
Celldex Therapeutics
Phase 2 Terminated
NCT01967758 2018-08-17
Phase I Study of Safety and Immunogenicity of ADU-623
Providence Health & Services
Phase 1 Completed
NCT02351037 2018-08-14
Study of Ibrutinib in Subjects With Acute Myeloid Leukemia
Pharmacyclics LLC.
Phase 2 Terminated
NCT01400555 2018-03-21
mCRPC
Cougar Biotechnology, Inc.
Phase 1 Completed